{"AOS": {"Ticker": "AOS", "Company": "A. O. Smith", "Sector": "Industrials", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Upgrade", "Organization": "Longbow", "Rating_Change": "Neutral to Buy", "Target_Change": "$71"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Longbow"], "Price_Target": 71.0}, "ABT": {"Ticker": "ABT", "Company": "Abbott Laboratories", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Underperform", "Target_Change": "$95"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wolfe Research"], "Price_Target": 95.0}, "AAPL": {"Ticker": "AAPL", "Company": "Apple", "Sector": "Information Technology", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$157 to $130"}, {"Date": "2022-06-28", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$210 to $180"}, {"Date": "2022-05-25", "Rating": "Reiterated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$210 to $180"}, {"Date": "2022-04-19", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$184"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Goldman", "Rosenblatt", "Loop Capital", "Evercore ISI"], "Price_Target": 168.5}, "BSX": {"Ticker": "BSX", "Company": "Boston Scientific", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$43"}, {"Date": "2022-05-27", "Rating": "Upgrade", "Organization": "Needham", "Rating_Change": "Hold to Buy", "Target_Change": "$48"}, {"Date": "2022-04-13", "Rating": "Resumed", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$52"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wolfe Research", "Needham", "Truist"], "Price_Target": 47.67}, "EOG": {"Ticker": "EOG", "Company": "EOG Resources", "Sector": "Energy", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$150"}, {"Date": "2022-05-24", "Rating": "Upgrade", "Organization": "Johnson Rice", "Rating_Change": "Hold to Buy", "Target_Change": "$155 to $165"}, {"Date": "2022-05-10", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Strong Buy", "Target_Change": "$170"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Johnson Rice", "Raymond James", "RBC Capital Mkts"], "Price_Target": 161.67}, "HCA": {"Ticker": "HCA", "Company": "HCA Healthcare", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Underperform", "Target_Change": "$233 to $160"}, {"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$240"}, {"Date": "2022-05-27", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$273 to $271"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Bernstein", "Loop Capital", "BMO Capital Markets"], "Price_Target": 223.67}, "HWM": {"Ticker": "HWM", "Company": "Howmet Aerospace", "Sector": "Industrials", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$41"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Truist"], "Price_Target": 41.0}, "MKC": {"Ticker": "MKC", "Company": "McCormick & Company", "Sector": "Consumer Staples", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Argus"], "Price_Target": -1.0}, "MCK": {"Ticker": "MCK", "Company": "McKesson Corporation", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-06-07", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$343 to $378"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Argus", "Deutsche Bank"], "Price_Target": 188.0}, "MDT": {"Ticker": "MDT", "Company": "Medtronic", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Underperform", "Target_Change": "$85"}, {"Date": "2022-06-01", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$125 to $105"}, {"Date": "2022-05-27", "Rating": "Downgrade", "Organization": "Needham", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-04-13", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$124 to $121"}], "Score": -1.25, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wolfe Research", "Atlantic Equities", "Truist", "Needham"], "Price_Target": 76.75}, "MRK": {"Ticker": "MRK", "Company": "Merck & Co.", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Upgrade", "Organization": "Daiwa Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$89 to $102"}, {"Date": "2022-06-06", "Rating": "Resumed", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$102"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Daiwa Securities", "SVB Leerink"], "Price_Target": 102.0}, "NFLX": {"Ticker": "NFLX", "Company": "Netflix", "Sector": "Communication Services", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$275 to $170"}, {"Date": "2022-06-14", "Rating": "Downgrade", "Organization": "The Benchmark Company", "Rating_Change": "Hold to Sell", "Target_Change": "$157"}, {"Date": "2022-06-10", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$265 to $186"}, {"Date": "2022-05-16", "Rating": "Upgrade", "Organization": "Wedbush", "Rating_Change": "Neutral to Outperform", "Target_Change": "$280"}, {"Date": "2022-04-21", "Rating": "Downgrade", "Organization": "Edward Jones", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-04-21", "Rating": "Downgrade", "Organization": "DZ Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$280"}, {"Date": "2022-04-20", "Rating": "Upgrade", "Organization": "Needham", "Rating_Change": "Underperform to Hold", "Target_Change": ""}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$355"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$460 to $300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Pivotal Research Group", "Rating_Change": "Buy to Sell", "Target_Change": "$235"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$562 to $293"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$605 to $300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Underperform", "Target_Change": "$605 to $300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$280"}, {"Date": "2022-04-19", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$354"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 17, "Period": "180 days", "Letter_Rating": "D", "Analists": ["The Benchmark Company", "Wells Fargo", "Atlantic Equities", "Stifel", "Barclays", "Rosenblatt", "Wedbush", "Piper Sandler", "JP Morgan", "Goldman", "Needham", "Pivotal Research Group", "Oppenheimer", "BofA Securities", "Edward Jones", "UBS", "DZ Bank"], "Price_Target": 219.94}, "PXD": {"Ticker": "PXD", "Company": "Pioneer Natural Resources", "Sector": "Energy", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$290"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["RBC Capital Mkts"], "Price_Target": 290.0}, "SRE": {"Ticker": "SRE", "Company": "Sempra Energy", "Sector": "Utilities", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$164 to $167"}, {"Date": "2022-04-26", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$180"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Goldman", "Credit Suisse"], "Price_Target": 173.5}, "TFX": {"Ticker": "TFX", "Company": "Teleflex", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$300"}, {"Date": "2022-05-09", "Rating": "Initiated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$315"}, {"Date": "2022-04-13", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Hold", "Target_Change": "$370"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wolfe Research", "BofA Securities", "Truist"], "Price_Target": 328.33}, "UNP": {"Ticker": "UNP", "Company": "Union Pacific", "Sector": "Industrials", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "Susquehanna", "Rating_Change": "Positive to Neutral", "Target_Change": "$235"}, {"Date": "2022-06-28", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$255"}, {"Date": "2022-05-26", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$245"}, {"Date": "2022-05-19", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$287 to $235"}, {"Date": "2022-04-22", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$283 to $267"}, {"Date": "2022-04-08", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$258"}], "Score": -0.83, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Citigroup", "Evercore ISI", "Susquehanna", "BofA Securities", "Credit Suisse", "UBS"], "Price_Target": 249.17}, "UHS": {"Ticker": "UHS", "Company": "Universal Health Services", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Underperform", "Target_Change": "$133 to $90"}, {"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Hold", "Target_Change": "$115"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Loop Capital", "BMO Capital Markets"], "Price_Target": 102.5}}